DekaBank Deutsche Girozentrale’s Rhythm Pharmaceuticals RYTM Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,000	Closed	-$525K	–	1311
2023 Q1	$525K	Hold	30,000	–	–	﹤0.01%	1003
2022 Q4	$890K	Hold	30,000	–	–	﹤0.01%	906
2022 Q3	$711K	Buy	+30,000	New	+$558K	﹤0.01%	967
2021 Q4	–	Sell	-12,000	Closed	-$157K	–	1473
2021 Q3	$157K	Hold	12,000	–	–	﹤0.01%	1244
2021 Q2	$239K	Hold	12,000	–	–	﹤0.01%	1187
2021 Q1	$243K	Hold	12,000	–	–	﹤0.01%	1151
2020 Q4	$357K	Sell	12,000 -600	-5%	-$15.2K	﹤0.01%	1092
2020 Q3	$278K	Buy	+12,600	New	+$289K	﹤0.01%	1007
2019 Q3	–	Sell	-26,000	Closed	-$564K	–	1101
2019 Q2	$564K	Buy	+26,000	New	+$657K	﹤0.01%	905

Other funds holding RYTM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RYTM Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2023, closing a stake of 30,000 shares — an estimated $525K sold.

DekaBank Deutsche Girozentrale first reported a position in RYTM in Q2 2019 and held it in 9 quarters. The position peaked at $890K in Q4 2022. 116 funds tracked by Wall St. Rank hold RYTM as of Q2 2023.

DekaBank Deutsche Girozentrale reported no remaining Rhythm Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 30,000 Rhythm Pharmaceuticals shares in Q2 2023, an estimated $525K.
DekaBank Deutsche Girozentrale first reported a position in Rhythm Pharmaceuticals in Q2 2019 and held it in 9 quarters.
DekaBank Deutsche Girozentrale's Rhythm Pharmaceuticals position peaked at $890K in Q4 2022.
116 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.